These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7915537)

  • 1. Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.
    Pazdur R; Lassere Y; Soh LT; Ajani JA; Bready B; Soo E; Sugarman S; Patt Y; Abbruzzese JL; Levin B
    Ann Oncol; 1994 May; 5(5):468-70. PubMed ID: 7915537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
    ten Bokkel Huinink WW; Prove AM; Piccart M; Steward W; Tursz T; Wanders J; Franklin H; Clavel M; Verweij J; Alakl M
    Ann Oncol; 1994 Jul; 5(6):527-32. PubMed ID: 7918124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.
    Clark TB; Kemeny NE; Conti JA; Huang Y; Andre AM; Stockman J
    Cancer Invest; 1998; 16(5):314-8. PubMed ID: 9627678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
    Hudis CA; Seidman AD; Crown JP; Balmaceda C; Freilich R; Gilewski TA; Hakes TB; Currie V; Lebwohl DE; Baselga J; Raptis G; Gollub M; Robles M; Bruno R; Norton L
    J Clin Oncol; 1996 Jan; 14(1):58-65. PubMed ID: 8558221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
    Catimel G; Verweij J; Mattijssen V; Hanauske A; Piccart M; Wanders J; Franklin H; Le Bail N; Clavel M; Kaye SB
    Ann Oncol; 1994 Jul; 5(6):533-7. PubMed ID: 7918125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel.
    Cortes JE; Pazdur R
    J Clin Oncol; 1995 Oct; 13(10):2643-55. PubMed ID: 7595719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.
    Mertens WC; Eisenhauer EA; Jolivet J; Ernst S; Moore M; Muldal A
    Ann Oncol; 1994 Feb; 5(2):185-7. PubMed ID: 7910480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel delivers new management opportunities for gastrointestinal carcinomas.
    Rougier P
    Anticancer Drugs; 1995 Jul; 6 Suppl 4():25-9. PubMed ID: 8745351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of Taxotere: five-day schedule.
    Pazdur R; Newman RA; Newman BM; Fuentes A; Benvenuto J; Bready B; Moore D; Jaiyesimi I; Vreeland F; Bayssas MM
    J Natl Cancer Inst; 1992 Dec; 84(23):1781-8. PubMed ID: 1359154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
    Fossella FV; Lee JS; Shin DM; Calayag M; Huber M; Perez-Soler R; Murphy WK; Lippman S; Benner S; Glisson B
    J Clin Oncol; 1995 Mar; 13(3):645-51. PubMed ID: 7884425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
    Moon C; Verschraegen CF; Bevers M; Freedman R; Kudelka AP; Kavanagh JJ
    Anticancer Drugs; 2000 Aug; 11(7):565-8. PubMed ID: 11036959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.
    Einzig AI; Neuberg D; Remick SC; Karp DD; O'Dwyer PJ; Stewart JA; Benson AB
    Med Oncol; 1996 Jun; 13(2):87-93. PubMed ID: 9013471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer.
    Shapiro JD; Millward MJ; Rischin D; Davison JD; Michael M; Francis PA; Ganju V; Toner GC
    Aust N Z J Med; 1997 Feb; 27(1):40-4. PubMed ID: 9079252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.
    Burris H; Irvin R; Kuhn J; Kalter S; Smith L; Shaffer D; Fields S; Weiss G; Eckardt J; Rodriguez G
    J Clin Oncol; 1993 May; 11(5):950-8. PubMed ID: 8098059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.
    Trudeau ME; Eisenhauer EA; Higgins BP; Letendre F; Lofters WS; Norris BD; Vandenberg TA; Delorme F; Muldal AM
    J Clin Oncol; 1996 Feb; 14(2):422-8. PubMed ID: 8636752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
    Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
    Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of docetaxel for cholangiocarcinoma.
    Pazdur R; Royce ME; Rodriguez GI; Rinaldi DA; Patt YZ; Hoff PM; Burris HA
    Am J Clin Oncol; 1999 Feb; 22(1):78-81. PubMed ID: 10025387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer.
    Dieras V; Chevallier B; Kerbrat P; Krakowski I; Roche H; Misset JL; Lentz MA; Azli N; Murawsky M; Riva A; Pouillart P; Fumoleau P
    Br J Cancer; 1996 Aug; 74(4):650-6. PubMed ID: 8761385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
    Papakostas P; Kouroussis C; Androulakis N; Samelis G; Aravantinos G; Kalbakis K; Sarra E; Souglakos J; Kakolyris S; Georgoulias V
    Eur J Cancer; 2001 Oct; 37(15):1833-8. PubMed ID: 11576836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of Taxotere (docetaxel) as a new treatment in breast cancer.
    Fumoleau P; Chevallier B; Kerbrat P; Dieras V; Azli N; Bayssas M; Van Glabbeke M
    Breast Cancer Res Treat; 1995; 33(1):39-46. PubMed ID: 7749131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.